Red cell transfusions in patients with hematologic malignancies

作者: Karen E. King , Paul M. Ness

DOI: 10.1007/978-1-4614-3764-2_55

关键词:

摘要: Although the transfusion of red cells is a relatively common clinical event, patients with hematologic malignancies have special requirements for their cell products and are at increased risk certain adverse effects transfusion. This chapter will provide an overview many basic principles medicine focus on issues which relevant to restoration oxygen carrying capacity in patient malignancy.

参考文章(138)
G Andreu, J Dewailly, C Leberre, MC Quarre, ML Bidet, R Tardivel, L Devers, Y Lam, E Soreau, C Boccaccio, Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration Blood. ,vol. 72, pp. 964- 969 ,(1988) , 10.1182/BLOOD.V72.3.964.964
Blumberg N, Heal Jm, Effects of transfusion on immune function. Cancer recurrence and infection. Archives of Pathology & Laboratory Medicine. ,vol. 118, pp. 371- 379 ,(1994)
Ernest Beutler, Lee Wood, The in vivo regeneration of red cell 2,3 diphosphoglyceric acid (DPG) after transfusion of stored blood. Journal of Laboratory and Clinical Medicine. ,vol. 74, pp. 300- 304 ,(1969) , 10.5555/URI:PII:0022214369901164
G. N. VYAS, L. HOLMDAHL, H. A. PERKINS, H. H. FUDENBERG, Serologic Specificity of Human Anti-IgA and its Significance in Transfusion Blood. ,vol. 34, pp. 573- 581 ,(1969) , 10.1182/BLOOD.V34.5.573.573
M Cazzola, L Ponchio, Y Beguin, V Rosti, G Bergamaschi, NL Liberato, V Fregoni, G Nalli, G Barosi, E Ascari, Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood. ,vol. 79, pp. 29- 37 ,(1992) , 10.1182/BLOOD.V79.1.29.BLOODJOURNAL79129
MARIO BALDINI, NICHOLAS COSTEA, WILLIAM DAMESHEK, ALVERA LIMAURO, The viability of stored human platelets. Blood. ,vol. 16, pp. 1669- 1692 ,(1960) , 10.1182/BLOOD.V16.6.1669.1669
James P. Aubuchon, Limiting Donor Exposure in Hemotherapy ,(1994)